Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunoprecise Antibodies Ltd

0.4268
-0.0022-0.51%
Volume:317.19K
Turnover:128.76K
Market Cap:19.53M
PE:-0.57
High:0.4268
Open:0.4200
Low:0.3861
Close:0.4290
Loading ...

Company Profile

Company Name:
Immunoprecise Antibodies Ltd
Exchange:
NASDAQ
Establishment Date:
1983
Employees:
87
Office Location:
3204–4464 Markham Street,Victoria,British Columbia,Canada
Zip Code:
V8Z 7X8
Fax:
- -
Introduction:
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.

Directors

Name
Position
James Kuo
Chairman
Jennifer Bath
CEO, President and Director
Greg Smith
Director
Lisa Helbling
Director
Robert Burke
Director

Shareholders

Name
Position
Brad McConn
Chief Financial Officer
Ilse Roodink
Chief Scientific Officer
Jennifer Bath
CEO, President and Director